CTIC

CTI BioPharma Corp. (DE) Common Stock

Delisted

CTIC was delisted on the 23rd of June, 2023.

43 hedge funds and large institutions have $40M invested in CTI BioPharma Corp. (DE) Common Stock in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+5
Holders Change %
+13.16%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
9
Reduced
10
Closed
3
Calls
$34K
Puts
Net Calls
+$34K
Net Calls Change
+$2K
Name Holding Trade Value Shares
Change
Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$10K +$46 +39 +0.5%
Morgan Stanley
27
Morgan Stanley
New York
$2K -$2.56K -2,469 -56%
Barclays
28
Barclays
United Kingdom
$2K +$1.26K +880 +170%
Federated Hermes
29
Federated Hermes
Pennsylvania
$1K -$2.19K -458 -69%
Osaic Holdings
30
Osaic Holdings
Arizona
$1K -$423 -340 -30%
CLOS
31
Compagnie Lombard Odier SCmA
Switzerland
$1K
Wells Fargo
32
Wells Fargo
California
$1K +$260 +158 +35%
GEA
33
Glen Eagle Advisors
New Jersey
$290
Citadel Advisors
34
Citadel Advisors
Florida
-$27K -29,289 Closed
Acadian Asset Management
35
Acadian Asset Management
Massachusetts
-$19K -20,524 Closed
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
-$250 -272 Closed